Medical Research
(H20Z)
AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$8.1M
Total Revenue
$8.3M
Total Expenses
N/A
Net Assets
0
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$32K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $8.1M | $8.3M | N/A | — | 0 |
| 2022 | $7.6M | $6.9M | N/A | — | 0 |
| 2021 | $5.5M | $4.8M | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.